Related Experiment Video
Updated: Jan 20, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
VDAC1 is regulated by BRD4 and contributes to JQ1 resistance in breast cancer
Guochao Yang1, Dianwei Zhou2, Jun Li3
1Department of General Surgery, Rongjun Hospital, Wuhan, Hubei 430079, P.R. China.
Abstract:
Voltage-dependent anion channels (VDACs) are situated in the outer membrane of the mitochondria and serve as gatekeepers that control metabolite and ion exchange between the cytosol and mitochondria. VDAC1 is one of the most studied members of the VDAC protein family and is overexpressed in multiple types of cancer. However, the specific biological function and regulatory mechanism of VDAC1 in breast cancer remains unclear. The present study investigated the biological role of VDAC1 in breast cancer cells using an MTS assay. The association of clinicopathological features with VDAC1 in breast cancer was analyzed by Gene Expression Profiling Interactive Analysis. The regulatory mechanism of VDAC1 was determined by cell transfection, western blot analysis, reverse transcription-quantitative (q)PCR analysis, chromatin immunoprecipitation (ChIP) and ChIP-qPCR analysis. The results of the present study demonstrated that VDAC1 promoted breast cancer proliferation and was associated with a poor prognosis in patients with breast cancer. Additionally, it was observed that the expression of VDAC1 could be decreased by the bromodomain inhibitor (JQ1), and bromodomain-containing protein 4 (BRD4) was indicated to be a regulator of VDAC1. Furthermore, results suggested that VDAC1 may be involved in the resistance of breast cancer to JQ1. Collectively, the present findings uncovered important aspects of the function of VDAC1 in the tumor progression of breast cancer, and may provide a basis for potential therapeutic strategies for the treatment of breast cancer.
Insights
Voltage-dependent anion channel 1 (VDAC1) promotes breast cancer growth and is linked to poor patient prognosis. BRD4 regulates VDAC1, which may contribute to therapeutic resistance in breast cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Voltage-dependent anion channels (VDACs) regulate mitochondrial transport.
- VDAC1 is overexpressed in various cancers, but its role in breast cancer is unclear.
Purpose of the Study:
- Investigate the biological role and regulatory mechanisms of VDAC1 in breast cancer.
- Determine VDAC1's association with clinicopathological features and patient prognosis.
Main Methods:
- MTS assay for cell proliferation.
- Gene Expression Profiling Interactive Analysis for clinical associations.
- Western blot, qPCR, ChIP, and ChIP-qPCR for regulatory analysis.
Main Results:
- VDAC1 overexpression promotes breast cancer cell proliferation.
- VDAC1 expression correlates with poor prognosis in breast cancer patients.
- Bromodomain inhibitor JQ1 reduces VDAC1 expression; BRD4 regulates VDAC1.
- VDAC1 may confer resistance to JQ1 in breast cancer.
Conclusions:
- VDAC1 plays a significant role in breast cancer progression.
- BRD4 is a key regulator of VDAC1 in breast cancer.
- VDAC1 presents a potential therapeutic target for breast cancer treatment.
Related Concept Videos
Treatment Resistant Cancers
Binet's Contribution to Measures of Intelligence
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Wechsler's Contribution to Measures of Intelligence
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...

